Haemonetics Receives FDA Clearance for New Plasma Collection System
Published: 10 Mar 2026
Author: Precedence Research
Haemonetics Corporation has received FDA 510(k) clearance for its NexSys PCS Plasma Collection System with Persona PLUS technology, which represents a milestone in the blood bank and plasma collection industry. The announcement was made on February 23, 2026, allowing commercial distribution of this advanced system throughout United States. The NexSys PCS system was developed to enhance the efficiency of plasma collection at donation centers.
The new Persona PLUS technology has been designed to allow operators to configure the plasma collection settings specific to each donor. This results in higher average volume of plasma collected per session and enhanced donor safety and comfort. This system will enable plasma centers to address the increasing demand for plasma-derived therapies by optimizing yield during the collection process and decreasing the variability of procedures. These benefits facilitate plasma operators to improve throughput without increasing the total donation time. The system is designed to use data-driven controls to optimize workflow while maintaining compliance with regulatory norms.
With the FDA approval of the NexSys PCS(Plasma Collection System) with Persona PLUS Technology, Haemonetics’ competitive position in the world market for plasma collection has now been greatly enhanced. It is anticipated that the launch of this new product will help to facilitate the expansion of Haemonetics’ commercial footprint within the U.S, which is one of the largest plasma collection markets in the world.
This approval comes at a time in the plasma collection industry when collection centers are looking for ways to improve their output at a time when there is significant demand and operational pressure on their operations. The NexSys PCS with Persona PLUS technology will now be included to the industry’s automated plasma collection technologies.
We focus exclusively on this industry and provide insights that help you make better decisions. Get in touch to learn more@ https://www.precedenceresearch.com/blood-bank-market